Dr Reddy's Labs

{
  "main_header": {
    "sid": 734514,
    "name": "Dr Reddy's Labs",
    "stock_name": "Dr Reddy's Labs",
    "full_name": "Dr Reddys Laboratories Ltd",
    "name_url": "stocks-analysis/dr-reddy-s-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,275.00",
    "chg": -19.25,
    "chgp": "-1.49%",
    "dir": -1,
    "prev_price": "1,294.25",
    "mcapval": "106,168.00 Cr",
    "mcap": "Large Cap",
    "scripcode": "500124",
    "symbol": "DRREDDY",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE089A01031",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "10.47 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-reddy-s-labs-734514-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-amid-mixed-market-signals-3899623",
        "imagepath": "",
        "date": "2026-03-19 09:21:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Dr Reddys Laboratories Ltd at the forefront of India’s equity landscape. The index, representing the top 50 companies by free-float market capitalisation, serves as a benchmark for institutional investors and mutual funds. Inclusion ensures enhanced liquidity, greater visibility, and often, a more stable investor base. For Dr Reddys, this status affirms its market leadership within the Pharmaceuticals & Biotechnology sector, which is critical given the sector’s evolving dynamics and competitive pressures.</p>\n                <p>With a market capitalisation of ₹1,05,867.42 crores, Dr Reddys comfortably qualifies as a large-cap entity, reinforcing its weight in the index. ..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership and Institutional Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-and-institutional-dynamics-3898159",
        "imagepath": "",
        "date": "2026-03-18 09:21:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index confers considerable advantages to Dr Reddys Laboratories Ltd, not least in terms of visibility and liquidity. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a benchmark for institutional investors and passive funds alike. Inclusion ensures that Dr Reddys benefits from consistent inflows from index-tracking funds, which can provide a stabilising effect on its share price during volatile market phases.</p>\n                <p>With a market capitalisation of ₹1,06,965 crores, Dr Reddys comfortably qualifies as a large-cap entity, reinforcing its eligibility for index membership. This status also e..."
      },
      {
        "title": "Dr Reddys Laboratories Upgraded to Hold on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-reddys-laboratories-upgraded-to-hold-on-technical-and-valuation-improvements-3895924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DrReddysLaborat_mojoScore_3895924.png",
        "date": "2026-03-17 08:31:44",
        "description": "Dr Reddys Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 16 March 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s long-term fundamentals and evolving market signals have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Downgrade Amid Mixed Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-downgrade-amid-mixed-market-performance-3892925",
        "imagepath": "",
        "date": "2026-03-16 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable advantages to Dr Reddys Laboratories Ltd, including enhanced visibility among institutional investors and inclusion in numerous index-tracking funds. This status often translates into increased liquidity and a stable investor base, which can cushion the stock against market volatility. The company’s large-cap stature and sector leadership in Pharmaceuticals & Biotechnology further reinforce its benchmark relevance.</p>\n                <p>However, membership also brings heightened scrutiny and performance expectations. Dr Reddys’ current mojo grade downgrade from Hold to Sell on 09 Mar 2026, with a mojo score of 48.0, signals a cautious stance from analysts,..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd’s Mixed Week: -0.84% Price Change Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltds-mixed-week--084-price-change-amid-technical-shifts-3891122",
        "imagepath": "",
        "date": "2026-03-14 13:06:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Mar:</strong> Stock opens at Rs.1,286.40 amid broad market weakness</p>\n                    <p><strong>10 Mar:</strong> Intraday high surge of 3.23% to Rs.1,326.50; Mojo Grade downgraded to Sell</p>\n                    <p><strong>11 Mar:</strong> Price rebounds with 2.28% gain to Rs.1,325.50; technical momentum shifts sideways</p>\n                    <p><strong>12-13 Mar:</strong> Price retreats, closing week at Rs.1,293.00 (-0.51% and -1.95% respectively)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,286.40</div></div>\n                    <div cl..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-navigating-nifty-50-membership-amid-mixed-market-signals-3888249",
        "imagepath": "",
        "date": "2026-03-13 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Dr Reddys Laboratories Ltd. The index membership ensures that the stock is a focal point for institutional investors, index funds, and exchange-traded funds (ETFs), which track the benchmark. This status often results in enhanced trading volumes and tighter bid-ask spreads, facilitating smoother price discovery. Moreover, inclusion in the Nifty 50 mandates adherence to stringent corporate governance and financial performance standards, which investors closely monitor.</p>\n                <p>Dr Reddys Laboratories Ltd’s market capitalisation stands robust at ₹1,09,960.04 crores, categorising it firmly as a large-cap ent..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Faces Downgrade Amidst Nifty 50 Membership Significance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-faces-downgrade-amidst-nifty-50-membership-significance-3886411",
        "imagepath": "",
        "date": "2026-03-12 09:21:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation Significance</strong></p>\n                <p>As a prominent large-cap stock with a market capitalisation of approximately ₹1,10,632 crores, Dr Reddys Laboratories Ltd holds a pivotal position within the Nifty 50 index. This membership not only reflects the company's substantial market footprint but also ensures heightened visibility among institutional investors and index funds. The stock’s inclusion in this benchmark index means it is a core holding for many passive investment vehicles, which can influence liquidity and price stability.</p>\n                <p>Currently trading at ₹1,315.10, the stock is just 4.78% shy of its 52-week high of ₹1,377.95, signalling a relatively strong price performance over the past year. This proximity..."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3884382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DrReddysLaborat_technicaldot_3884382.png",
        "date": "2026-03-11 08:02:33",
        "description": "Dr Reddys Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with mildly bearish monthly trends and daily moving averages. This nuanced technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Dr Reddys Laboratories Ltd Hits Intraday High with 3.23% Surge on 10 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-reddys-laboratories-ltd-hits-intraday-high-with-323-surge-on-10-mar-2026-3882879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DrReddysLaborat_priceRelatedfactors_3882879.png",
        "date": "2026-03-10 13:01:02",
        "description": "Dr Reddys Laboratories Ltd recorded a robust intraday performance on 10 Mar 2026, surging to an intraday high of Rs 1326.5, marking a 3.12% increase and closing the day with a 3.23% gain. This rise outpaced the broader Sensex index and the Pharmaceuticals & Biotechnology sector, reflecting a notable rebound after two days of declines."
      }
    ],
    "total": 500,
    "sid": "734514",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-reddys-laboratories-734514"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "17-Mar-2026",
      "details": "Disclosure under regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "13-Mar-2026",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "12-Mar-2026",
      "details": "Allotment of Employee Stock Options",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has declared <strong>800%</strong> dividend, ex-date: 10 Jul 25",
          "dt": "2025-07-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:5</strong> stock split, ex-date: 28 Oct 24",
          "dt": "2024-10-28",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Reddys Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 28 Aug 06",
          "dt": "2006-08-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals

2026-03-19 09:21:02

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Dr Reddys Laboratories Ltd at the forefront of India’s equity landscape. The index, representing the top 50 companies by free-float market capitalisation, serves as a benchmark for institutional investors and mutual funds. Inclusion ensures enhanced liquidity, greater visibility, and often, a more stable investor base. For Dr Reddys, this status affirms its market leadership within the Pharmaceuticals & Biotechnology sector, which is critical given the sector’s evolving dynamics and competitive pressures.

With a market capitalisation of ₹1,05,867.42 crores, Dr Reddys comfortably qualifies as a large-cap entity, reinforcing its weight in the index. ...

Read full news article

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership and Institutional Dynamics

2026-03-18 09:21:05

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index confers considerable advantages to Dr Reddys Laboratories Ltd, not least in terms of visibility and liquidity. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a benchmark for institutional investors and passive funds alike. Inclusion ensures that Dr Reddys benefits from consistent inflows from index-tracking funds, which can provide a stabilising effect on its share price during volatile market phases.

With a market capitalisation of ₹1,06,965 crores, Dr Reddys comfortably qualifies as a large-cap entity, reinforcing its eligibility for index membership. This status also e...

Read full news article

Dr Reddys Laboratories Upgraded to Hold on Technical and Valuation Improvements

2026-03-17 08:31:44

Dr Reddys Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 16 March 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s long-term fundamentals and evolving market signals have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Dr Reddys Laboratories Ltd Faces Downgrade Amid Mixed Market Performance

2026-03-16 09:20:51

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable advantages to Dr Reddys Laboratories Ltd, including enhanced visibility among institutional investors and inclusion in numerous index-tracking funds. This status often translates into increased liquidity and a stable investor base, which can cushion the stock against market volatility. The company’s large-cap stature and sector leadership in Pharmaceuticals & Biotechnology further reinforce its benchmark relevance.

However, membership also brings heightened scrutiny and performance expectations. Dr Reddys’ current mojo grade downgrade from Hold to Sell on 09 Mar 2026, with a mojo score of 48.0, signals a cautious stance from analysts,...

Read full news article

Dr Reddys Laboratories Ltd’s Mixed Week: -0.84% Price Change Amid Technical Shifts

2026-03-14 13:06:11

Key Events This Week

09 Mar: Stock opens at Rs.1,286.40 amid broad market weakness

10 Mar: Intraday high surge of 3.23% to Rs.1,326.50; Mojo Grade downgraded to Sell

11 Mar: Price rebounds with 2.28% gain to Rs.1,325.50; technical momentum shifts sideways

12-13 Mar: Price retreats, closing week at Rs.1,293.00 (-0.51% and -1.95% respectively)

Week Open

Rs.1,286.40

Read full news article

Dr Reddys Laboratories Ltd: Navigating Nifty 50 Membership Amid Mixed Market Signals

2026-03-13 09:20:58

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Dr Reddys Laboratories Ltd. The index membership ensures that the stock is a focal point for institutional investors, index funds, and exchange-traded funds (ETFs), which track the benchmark. This status often results in enhanced trading volumes and tighter bid-ask spreads, facilitating smoother price discovery. Moreover, inclusion in the Nifty 50 mandates adherence to stringent corporate governance and financial performance standards, which investors closely monitor.

Dr Reddys Laboratories Ltd’s market capitalisation stands robust at ₹1,09,960.04 crores, categorising it firmly as a large-cap ent...

Read full news article

Dr Reddys Laboratories Ltd Faces Downgrade Amidst Nifty 50 Membership Significance

2026-03-12 09:21:05

Index Membership and Market Capitalisation Significance

As a prominent large-cap stock with a market capitalisation of approximately ₹1,10,632 crores, Dr Reddys Laboratories Ltd holds a pivotal position within the Nifty 50 index. This membership not only reflects the company's substantial market footprint but also ensures heightened visibility among institutional investors and index funds. The stock’s inclusion in this benchmark index means it is a core holding for many passive investment vehicles, which can influence liquidity and price stability.

Currently trading at ₹1,315.10, the stock is just 4.78% shy of its 52-week high of ₹1,377.95, signalling a relatively strong price performance over the past year. This proximity...

Read full news article

Dr Reddys Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-11 08:02:33

Dr Reddys Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with mildly bearish monthly trends and daily moving averages. This nuanced technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Dr Reddys Laboratories Ltd Hits Intraday High with 3.23% Surge on 10 Mar 2026

2026-03-10 13:01:02

Dr Reddys Laboratories Ltd recorded a robust intraday performance on 10 Mar 2026, surging to an intraday high of Rs 1326.5, marking a 3.12% increase and closing the day with a 3.23% gain. This rise outpaced the broader Sensex index and the Pharmaceuticals & Biotechnology sector, reflecting a notable rebound after two days of declines.

Read full news article

View All News